Vestmark Advisory Solutions’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTX
MI
Vestmark Advisory Solutions's AKTX Position: Q3 2026 in Review
Vestmark Advisory Solutions opened a new position in Akari Therapeutics (AKTX) in Q3 2026: 37,688 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #1394 among its holdings.
13 funds tracked by Wall St. Rank hold AKTX as of Q3 2026.
- Vestmark Advisory Solutions held 37,688 shares of Akari Therapeutics worth $350K as of Q3 2026.
- Akari Therapeutics was a new Vestmark Advisory Solutions position in Q3 2026.
- Akari Therapeutics made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q3 2026, its #1394 holding.
- 13 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.